Related references
Note: Only part of the references are listed.The redox requirements of proliferating mammalian cells
Aaron M. Hosios et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Telomerase and N-Cadherin Differential Importance in Adrenocortical Cancers and Adenomas
Sofia S. Pereira et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Siyuan Zheng et al.
CANCER CELL (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?
Nissim Hay
NATURE REVIEWS CANCER (2016)
Structure and function of mitochondrial membrane protein complexes
Werner Kuehlbrandt
BMC BIOLOGY (2015)
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors
Beatrice Rubin et al.
CANCER INVESTIGATION (2015)
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors
Helene Myrtue Nielsen et al.
ENDOCRINE-RELATED CANCER (2015)
Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment
Rossella Libe
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors
Annabel S. Berthon et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2015)
Adrenocortical Carcinoma
Tobias Else et al.
ENDOCRINE REVIEWS (2014)
p38 MAPK regulates steroidogenesis through transcriptional repression of STAR gene
Syed Kashif Zaidi et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
NMR-based evaluation of the metabolic profile and response to dichloroacetate of human prostate cancer cells
Mithun Kailavasan et al.
NMR IN BIOMEDICINE (2014)
BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications
Eftychia Oikonomou et al.
ONCOTARGET (2014)
Redox Imbalance and Biochemical Changes in Cancer
Tonia C. Jorgenson et al.
CANCER RESEARCH (2013)
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
Kamal S. Saini et al.
CANCER TREATMENT REVIEWS (2013)
The effect of mitotane on viability, steroidogenesis and gene expression in NCI-H295R adrenocortical cells
Tomasz P. Lehmann et al.
MOLECULAR MEDICINE REPORTS (2013)
ARMC5 Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome
Guillaume Assie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The emerging role of the molecular marker p27 in the differential diagnosis of adrenocortical tumors
Sofia S. Pereira et al.
ENDOCRINE CONNECTIONS (2013)
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Berruti et al.
ANNALS OF ONCOLOGY (2012)
TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
Leonie J. M. Herrmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
MAMMALIAN MAPK SIGNAL TRANSDUCTION PATHWAYS ACTIVATED BY STRESS AND INFLAMMATION: A 10-YEAR UPDATE
John M. Kyriakis et al.
PHYSIOLOGICAL REVIEWS (2012)
Adrenocortical carcinoma: a clinician's update
Martin Fassnacht et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Substrate selection in hearts subjected to ischemia/reperfusion: role of cardioplegic solutions and gender
Marco G. Alves et al.
NMR IN BIOMEDICINE (2011)
The prevalence of adrenal incidentaloma in routine clinical practice
Colin Davenport et al.
ENDOCRINE (2011)
Pathological roles of MAPK signaling pathways in human diseases
Eun Kyung Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
Bruno Ragazzon et al.
CANCER RESEARCH (2010)
Reactive oxygen species, cellular redox systems, and apoptosis
Magdalena L. Circu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Cardiovascular Disease in Cushing's Syndrome: Heart versus Vasculature
Monica De Leo et al.
NEUROENDOCRINOLOGY (2010)
Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinomas
Martin Fassnacht et al.
CANCER (2009)
Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas
Vassiliki Kotoula et al.
ENDOCRINE-RELATED CANCER (2009)
Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors
G. Masi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2009)
Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane
A. Stigliano et al.
ENDOCRINE-RELATED CANCER (2008)
Oxidative stress-induced inhibition of adrenal steroidogenesis requires participation of p38 mitogen-activated protein kinase signaling pathway
Parveen Abidi et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Clinical experience of MEK inhibitors in cancer therapy
Ding Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Adjuvant mitotane treatment for adrenocortical carcinoma
Massimo Terzolo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter
Walter L. Miller
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
Clinical review: Adrenocortical carcinoma: Clinical update
Bruno Allolio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Cl-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK)
LF Allen et al.
SEMINARS IN ONCOLOGY (2003)
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1
MS Squires et al.
BIOCHEMICAL JOURNAL (2002)
Clinical management of malignant adrenal tumors
D Kopf et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
PCR-SSCP analysis of human adrenocortical adenomas: absence of K-ras gene mutations
M Ocker et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)
Share Paper
